Tag Archives: NPO

Top 10 Medical Stocks To Own Right Now

Northwestern Mutual Investment Management Company LLC reduced its position in Waters Co. (NYSE:WAT) by 20.2% in the 1st quarter, HoldingsChannel.com reports. The firm owned 14,340 shares of the medical instruments supplier’s stock after selling 3,624 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in Waters were worth $2,849,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Banco de Sabadell S.A bought a new position in Waters in the fourth quarter worth $193,000. Brown Advisory Securities LLC acquired a new position in Waters during the fourth quarter worth $202,000. Trust Co. of Virginia VA acquired a new position in Waters during the fourth quarter worth $213,000. Rockefeller Capital Management L.P. acquired a new position in Waters during the first quarter worth $272,000. Finally, Jane Street Group LLC acquired a new position in Waters during the fourth quarter worth $294,000. 92.21% of the stock is owned by hedge funds and other institutional investors.

Top 10 Medical Stocks To Own Right Now: Enpro Industries(NPO)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about EnPro Industries (NYSE:NPO) has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. EnPro Industries earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave news articles about the industrial products company an impact score of 46.9443513305379 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Max Byerly]

    EnPro Industries, Inc. (NYSE:NPO) SVP Jon D. Rickers sold 500 shares of the firm’s stock in a transaction on Thursday, August 23rd. The stock was sold at an average price of $75.63, for a total value of $37,815.00. Following the completion of the transaction, the senior vice president now owns 6,215 shares of the company’s stock, valued at approximately $470,040.45. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

  • [By Max Byerly]

    EnPro Industries, Inc. (NYSE:NPO) has been assigned an average rating of “Hold” from the eight research firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $91.60.

Top 10 Medical Stocks To Own Right Now: Lorillard Inc(LO)

Advisors’ Opinion:

  • [By Shane Hupp]

    News articles about Lorillard (NYSE:LO) have been trending extremely positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lorillard earned a news impact score of 0.81 on Accern’s scale. Accern also gave news coverage about the company an impact score of 44.1727475800447 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top 10 Medical Stocks To Own Right Now: Brandywine Realty Trust(BDN)

Advisors’ Opinion:

  • [By Max Byerly]

    Brandywine Realty Trust (NYSE:BDN) has received an average recommendation of “Hold” from the ten research firms that are currently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $18.17.

  • [By Lee Jackson]

    This is one of the top REITs and a solid buy at current levels. Brandywine Realty Trust (NYSE: BDN) is an office REIT headquartered in Philadelphia that own, develops and operates primarily office buildings in downtown and suburban Philadelphia, Northern Virginia and Austin, Texas.

  • [By Ethan Ryder]

    Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Brandywine Realty Trust (NYSE:BDN) by 5.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 168,439 shares of the real estate investment trust’s stock after buying an additional 8,253 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.09% of Brandywine Realty Trust worth $2,675,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    First Trust Advisors LP grew its stake in shares of Brandywine Realty Trust (NYSE:BDN) by 102.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 589,822 shares of the real estate investment trust’s stock after acquiring an additional 298,129 shares during the period. First Trust Advisors LP owned 0.33% of Brandywine Realty Trust worth $7,591,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Media stories about Brandywine Realty Trust (NYSE:BDN) have trended positive this week, according to Accern. The research group rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Brandywine Realty Trust earned a news sentiment score of 0.33 on Accern’s scale. Accern also assigned news articles about the real estate investment trust an impact score of 46.6385755887637 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 10 Medical Stocks To Own Right Now: Morningstar, Inc.(MORN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Morningstar, Inc. (NASDAQ:MORN) insider Joseph D. Mansueto sold 9,203 shares of the company’s stock in a transaction dated Wednesday, September 26th. The stock was sold at an average price of $128.51, for a total transaction of $1,182,677.53. Following the transaction, the insider now owns 23,058,333 shares in the company, valued at approximately $2,963,226,373.83. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

  • [By Ethan Ryder]

    Northern Trust Corp grew its position in Morningstar, Inc. (NASDAQ:MORN) by 4.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 227,049 shares of the business services provider’s stock after buying an additional 9,963 shares during the quarter. Northern Trust Corp’s holdings in Morningstar were worth $21,688,000 at the end of the most recent reporting period.

  • [By Motley Fool Staff]

    In this episode of Industry Focus: Financials, host Shannon Jones and guest Matt Frankel walk through how Morningstar (NASDAQ:MORN), Credit Acceptance Corp. (NASDAQ:CACC), and SVB Financial Group (NASDAQ:SIVB) have all crushed their peers and risen by more than 35% so far this year.

  • [By Shane Hupp]

    Morningstar, Inc. (NASDAQ:MORN) reached a new 52-week high and low during mid-day trading on Thursday . The company traded as low as $111.91 and last traded at $111.20, with a volume of 784 shares trading hands. The stock had previously closed at $111.35.

  • [By Ethan Ryder]

    Morningstar, Inc. (NASDAQ:MORN) reached a new 52-week high and low on Wednesday . The company traded as low as $114.71 and last traded at $114.20, with a volume of 975 shares changing hands. The stock had previously closed at $113.06.

Top 10 Medical Stocks To Own Right Now: Brightcove Inc.(BCOV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Brightcove (NASDAQ:BCOV) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern’s scoring:

    Get Brightcove alerts:

    Critical Analysis: Brightcove (BCOV) vs. Smartsheet (SMAR) (americanbankingnews.com) Brightcove (BCOV) PT Raised to $13.00 at Stifel Nicolaus (americanbankingnews.com) Brightcove Pushes the Envelope with Video Experiences that Increase Customer ROI (finance.yahoo.com) Brightcove Launches OTT Flow X, Powered by Accedo (finance.yahoo.com)

    A number of research analysts have recently issued reports on BCOV shares. Zacks Investment Research cut shares of Brightcove from a “buy” rating to a “hold” rating in a research note on Wednesday, April 25th. Dougherty & Co lifted their target price on shares of Brightcove from $11.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, May 17th. BidaskClub upgraded shares of Brightcove from a “hold” rating to a “buy” rating in a research report on Saturday, April 28th. TheStreet upgraded shares of Brightcove from a “d+” rating to a “c-” rating in a research report on Monday, May 7th. Finally, Stifel Nicolaus boosted their price objective on shares of Brightcove from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, May 22nd. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $9.85.

  • [By Motley Fool Transcribers]

    Brightcove Inc  (NASDAQ:BCOV)Q4 2018 Earnings Conference CallFeb. 13, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: Harmonic Inc.(HLIT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Harmonic (HLIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Harmonic Inc  (NASDAQ:HLIT)Q4 2018 Earnings Conference CallFeb. 04, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Harmonic (NASDAQ:HLIT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Thursday.

  • [By Max Byerly]

    Digital Ally (NASDAQ: HLIT) and Harmonic (NASDAQ:HLIT) are both small-cap industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Emergent Capital, Inc.(EMG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Man Group PLC (LON:EMG) has earned an average rating of “Buy” from the seven research firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is GBX 183 ($2.39).

Top 10 Medical Stocks To Own Right Now: China Jo-Jo Drugstores, Inc.(CJJD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about China Jo-Jo Drugstores (NASDAQ:CJJD) has trended positive on Saturday, Accern reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Jo-Jo Drugstores earned a media sentiment score of 0.28 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 48.5554072096128 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top 10 Medical Stocks To Own Right Now: Potash Corporation of Saskatchewan Inc.(POT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    PotCoin (CURRENCY:POT) traded 0.6% higher against the US dollar during the 24 hour period ending at 23:00 PM E.T. on May 12th. PotCoin has a total market capitalization of $23.95 million and approximately $62,522.00 worth of PotCoin was traded on exchanges in the last 24 hours. During the last seven days, PotCoin has traded 17.8% lower against the US dollar. One PotCoin coin can now be purchased for approximately $0.11 or 0.00001293 BTC on popular cryptocurrency exchanges including Cryptopia, CoinExchange, Trade By Trade and Tux Exchange.

  • [By Shane Hupp]

    Media stories about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended somewhat positive recently, Accern reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Potash Co. of Saskatchewan earned a daily sentiment score of 0.23 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.852138495875 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Ethan Ryder]

    Headlines about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Potash Co. of Saskatchewan earned a news impact score of 0.43 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.4285202328488 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Max Byerly]

    PotCoin (CURRENCY:POT) traded 4% lower against the U.S. dollar during the 24-hour period ending at 0:00 AM Eastern on June 4th. PotCoin has a total market capitalization of $18.72 million and approximately $73,221.00 worth of PotCoin was traded on exchanges in the last 24 hours. In the last seven days, PotCoin has traded up 2.6% against the U.S. dollar. One PotCoin coin can now be purchased for approximately $0.0850 or 0.00001147 BTC on exchanges including CoinExchange, Tux Exchange, Trade By Trade and Bleutrade.

Top 10 Medical Stocks To Own Right Now: National Oilwell Varco, Inc.(NOV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on National Oilwell Varco (NOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Oil prices crashed 40% from their peak early in the fourth quarter, which caused some oil producers to abruptly change their plans. While that impacted National Oilwell Varco’s (NYSE:NOV) financial results, it wasn’t as bad as analysts feared as the company managed to beat revenue expectations while remaining profitable.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “National-Oilwell Varco (NOV) Shares Gap Down to $26.58” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/4207620/national-oilwell-varco-nov-shares-gap-down-to-26-58.html.